Indivior loses U.S. district court battle, copycat launches imminent

Share this post

Generic competitors to British drugmaker Indivior Plc’s blockbuster opioid addiction treatment are on course to launch sales next week after the firm’s attempt to stay a U.S. District court judgement was rejected.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply